Delivery Order SPE2DB20D2104-SPE2DB21FT44Z
- Not listed
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,303.02, was awarded by the Defense Logistics Agency (DLA) for the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held...
- This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA). The contract, valued at $98,877.10, is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. The contract covers the delivery of a wide range of pharmaceutical...
- This federal contract award is for a pharmaceutical prime vendor contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through November 2026. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award is for a prime vendor pharmaceutical contract valued at $1,829.75, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Prime Vendor Pharmaceutical contract with the Defense Logistics Agency (DLA) valued at $7,181.84. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal...
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,500.41 and was awarded by the Defense Logistics Agency (DLA), a defense agency, to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is an Indefinite...
- This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Defense Logistics Agency (DLA) awarded this $2,653.20 firm fixed-price delivery order under the company's larger $999,999,999 Indefinite Delivery Contract (IDC) for pharmaceutical and medical supply distribution to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract covers a range of...
- This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at up to $1,366.56, was awarded by the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Firm Fixed Price Delivery...
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $1,664.49, was awarded by the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 and running through November 2026,...
- This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,273.45 delivery order was issued by the Defense Logistics Agency (DLA) for pharmaceutical and medical supply products to support military treatment facilities and veterans' healthcare programs. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as a primary vehicle for Amerisourcebergen to deliver a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FT44ZDelivery Order
This federal contract award is for a Prime Vendor Pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,386.15, was awarded by the Defense Logistics Agency (DLA) and is for the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to provide essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen's extensive pharmaceutical distribution capabilities and experience in serving federal healthcare programs make it a critical supplier for the DLA and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/27/21 |